Bioventus Inc. Quarterly Assets, Current in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Bioventus Inc. quarterly Assets, Current history and growth rate from Q4 2020 to Q2 2024.
  • Bioventus Inc. Assets, Current for the quarter ending June 29, 2024 was $309M, a 18.5% increase year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $309M +$48.2M +18.5% Jun 29, 2024 10-Q 2024-08-06
Q1 2024 $266M -$42.8M -13.9% Mar 30, 2024 10-Q 2024-05-07
Q4 2023 $268M -$4.58M -1.68% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $249M -$21.6M -7.98% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $261M -$16.5M -5.96% Jul 1, 2023 10-Q 2023-08-08
Q1 2023 $309M +$63.3M +25.8% Apr 1, 2023 10-Q 2023-05-16
Q4 2022 $273M +$9.47M +3.6% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $271M +$25M +10.2% Oct 1, 2022 10-Q 2022-11-21
Q2 2022 $277M -$12.9M -4.45% Jul 2, 2022 10-Q 2022-08-12
Q1 2022 $245M -$25.3M -9.36% Apr 2, 2022 10-Q 2022-05-11
Q4 2021 $263M +$51.3M +24.2% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $246M Oct 2, 2021 10-Q 2021-11-10
Q2 2021 $290M Jul 3, 2021 10-Q 2021-08-11
Q1 2021 $271M Apr 3, 2021 10-Q 2021-05-13
Q4 2020 $212M Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.